Patented Medicine Prices Review Board (PMPRB)
119 disclosed lobbying communications with this institution.
119
Total communications
5
Communications, 2024
Communications by year
200820162024
Top subject matters
| Health89 | 89 | |
|---|---|---|
| Industry61 | 61 | |
| Intellectual Property30 | 30 | |
| Research and Development16 | 16 | |
| Science and Technology14 | 14 | |
| Economic Development9 | 9 | |
| Consumer Issues7 | 7 | |
| International Trade5 | 5 | |
| Budget2 | 2 | |
| Taxation and Finance2 | 2 |
Top organizations communicating
Recent communications
| Date | Lobbyist | DPOH | Title | Organization |
|---|---|---|---|---|
| 2026-08-07 | Stephen Frank | Guillaume Couillard | Director General | Canadian Life and Health Insurance Association Inc. |
| 2026-06-02 | Alan Walshe | Anie Perrault | Chairperson | Takeda Canada Inc. |
| 2026-02-04 | Terry Creighton | Guillaume Couillard | Director General | Canadian Pharmaceutical Manufacturers and Exporters Alliance |
| 2026-02-04 | Raymond Shelley | Guillaume Couillard | Director General | Apotex Inc. |
| 2026-02-04 | David Goodman | Guillaume Couillard | Directeur général | Pharmascience Inc. |
| 2026-02-04 | David Goodman | Kevin Pothier | Directeur principal, Politiques et de l'analyse économique | Pharmascience Inc. |
| 2025-07-30 | Joan Eliasek | Guillaume Couillard | Director General | McKesson Canada |
| 2025-07-17 | Joan Eliasek | Anie Perrault | Acting Chairperson | McKesson Canada |
| 2025-04-22 | Bettina Hamelin | Anie Perrault | Acting Chairperson | Innovative Medicines Canada |
| 2024-09-06 | Michal Juul Sørensen | Thomas J. Digby | Chairperson | Lundbeck Canada Inc. |
| 2024-08-08 | GERALD JEFFCOTT | Guillaume Couillard | Director General | RAREi - The Canadian Forum for Rare Disease Innovators |
| 2024-08-08 | WILLIAM DEMPSTER | Guillaume Couillard | Executive Director | RAREi - The Canadian Forum for Rare Disease Innovators |
| 2024-06-17 | JAMES KEON | Guillaume Couillard | Executive Director | Canadian Generic Pharmaceutical Association (CGPA) |
| 2024-05-01 | JAMES KEON | Guillaume Couillard | Executive Director | Canadian Generic Pharmaceutical Association (CGPA) |
| 2023-12-06 | Hugues Mousseau | Thomas Digby | Président | Québec Association of Pharmacy Distributors |
| 2023-12-06 | Hugues Mousseau | Anie Perrault | Vice-présidente du Conseil | Québec Association of Pharmacy Distributors |
| 2023-12-06 | Hugues Mousseau | Carolyn Kobernick | Membre du Conseil | Québec Association of Pharmacy Distributors |
| 2023-12-06 | Hugues Mousseau | Guillaume Couillard | Directeur exécutif par intérim | Québec Association of Pharmacy Distributors |
| 2023-10-06 | WILLIAM DEMPSTER | Guillaume Couillard | Executive Director | RAREi - The Canadian Forum for Rare Disease Innovators |
| 2023-07-21 | Pamela Fralick | Thomas Digby | Chairperson | Innovative Medicines Canada |
| 2023-05-17 | Sylvia Durgerian | Thomas Digby | Chairperson to the Patented Medicine Prices Review Board (PMPRB) | IQVIA Solutions Canada Inc. |
| 2022-12-05 | WILLIAM DEMPSTER | Douglas Clark | Executive Director | RAREi - The Canadian Forum for Rare Disease Innovators |
| 2022-12-05 | GERALD JEFFCOTT | Douglas Clark | Executive Director | RAREi - The Canadian Forum for Rare Disease Innovators |
| 2022-11-29 | BRIGITTE NOLET | Douglas Clark | Executive Director | Hoffmann-La Roche Limited |
| 2022-10-27 | Rhonda Pacheco | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2022-10-19 | Kevin Strain | Douglas Clark | Executive Director | Sun Life Financial Inc. |
| 2022-07-07 | WILLIAM DEMPSTER | Tanya Potashnik | Director of Policy and Economic Analysis | RAREi - The Canadian Forum for Rare Disease Innovators |
| 2022-07-07 | GERALD JEFFCOTT | Tanya Potashnik | Director of Policy and Economic Analysis | RAREi - The Canadian Forum for Rare Disease Innovators |
| 2022-06-10 | Kevin Strain | Douglas Clark | Executive Director | Sun Life Financial Inc. |
| 2022-06-07 | Paul Mahon | Douglas Clark | Executive Director | The Canada Life Assurance Company |
| 2022-06-01 | Faris El-Refaie | Douglas Clark | Executive Director | GlaxoSmithKline Inc. |
| 2022-05-24 | Rhonda Pacheco | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2022-04-14 | Tracey Ramsay | Douglas Clark | Executive Director | AbbVie Corporation |
| 2022-04-07 | Rhonda Pacheco | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2020-12-14 | Ian Chesney | Doug Clark | Executive Director | Takeda Canada Inc. |
| 2020-12-09 | Kate Dalgleish | Douglas Clark | Executive Director | Sunovion Pharmaceuticals Canada Inc. |
| 2020-12-09 | Kate Dalgleish | Tanya Potashnik | Director | Sunovion Pharmaceuticals Canada Inc. |
| 2020-12-09 | Kate Dalgleish | Elena Lungu | Manager | Sunovion Pharmaceuticals Canada Inc. |
| 2020-12-09 | Kate Dalgleish | Isabel Jaen Raasch | General Counsel | Sunovion Pharmaceuticals Canada Inc. |
| 2020-10-22 | Rhonda Pacheco | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2020-10-07 | Rhonda Pacheco | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2020-08-12 | Michael Siauw | Douglas Clark | Executive Director | Vertex Pharmaceuticals (Canada) Incorporated |
| 2020-06-05 | Rhonda Pacheco | Doug Clark | Executive Director | Eli Lilly Canada Inc. |
| 2020-05-15 | Rhonda Pacheco | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2020-01-22 | RUSSELL WILLIAMS | Douglas Clark | Executive Director | Diabetes Canada |
| 2019-12-10 | Andrea Seale | Douglas Clark | Executive Director | CANADIAN CANCER SOCIETY |
| 2019-07-29 | Ian Chesney | Douglas Clark | Executive Director | Takeda Canada Inc. |
| 2019-05-29 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2019-03-07 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2018-12-11 | Brian Hilberdink | Doug Clark | Executive Director | Novo Nordisk Canada Inc. |
| 2018-12-11 | Brian Hilberdink | Tanya Potashnick | Director | Novo Nordisk Canada Inc. |
| 2018-12-11 | Brian Hilberdink | Matthew Kellison | Director | Novo Nordisk Canada Inc. |
| 2018-12-04 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2018-10-25 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2018-09-11 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2018-06-28 | Yoo-Seok Hong | Doug Clark | Executive Director | GlaxoSmithKline Inc. |
| 2018-05-08 | Brian Hilberdink | Douglas Clark | Executive Director | Novo Nordisk Canada Inc. |
| 2018-04-10 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2018-04-09 | ANDREW CASEY | Douglas Clark | Executive Director | BIOTECANADA |
| 2018-03-07 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2017-10-12 | Janice Murray | Anju Dhillon | Member of Parliament - Dorval-Lachine-Lasalee | Novartis Pharmaceuticals Canada Inc. |
| 2017-10-10 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2017-07-26 | RONNIE MILLER | Douglas Clark | Executive Director | Hoffmann-La Roche Limited |
| 2017-05-23 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2017-02-13 | Helen Jordan | Douglas Clark | Director General | Amgen Canada Inc. |
| 2016-11-22 | Jacques Dessureault | Douglas Clark | Executive Director | Bausch Health, Canada Inc. |
| 2016-10-12 | JAMES KEON | Doug Clark | Executive Director | Canadian Generic Pharmaceutical Association (CGPA) |
| 2016-10-12 | Douglas Sommerville | Douglas Clark | Executive Director | Teva Canada Limited |
| 2016-10-12 | Jeremy Desai | Doug Clark | Executive Director | Apotex Inc. |
| 2016-10-11 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2016-07-14 | Paul Lirette | Douglas Clark | Executive Director | GlaxoSmithKline Inc. |
| 2016-06-07 | Douglas Sommerville | Douglas Clark | Executive Director | Teva Canada Limited |
| 2016-06-07 | Douglas Sommerville | Ginette Tognet | Director | Teva Canada Limited |
| 2016-06-07 | Douglas Sommerville | Jarrett Todd | Regulatory Officer | Teva Canada Limited |
| 2016-06-07 | Douglas Sommerville | Isabel Jaen Raasch | General Counsel | Teva Canada Limited |
| 2016-05-09 | Lisa Matar | Douglas Clark | Executive Director | Eli Lilly Canada Inc. |
| 2016-04-01 | Helen Jordan | Douglas Clark | Executive Director | Amgen Canada Inc. |
| 2015-07-29 | Helen Jordan | Elena Lungu | Senior Economic Analyst | Amgen Canada Inc. |
| 2015-07-29 | Helen Jordan | Jeffrey Biggs | Manager, Policy Development | Amgen Canada Inc. |
| 2015-07-29 | Helen Jordan | Branka Pejcic-Karapetrovic | Pharmaceutical Analyst/Research | Amgen Canada Inc. |
| 2015-02-17 | ANDREW CASEY | Doug Clark | Executive Director | BIOTECANADA |
| 2014-11-04 | Helen Long | John Baird | member of parliament | CANADIAN HEALTH FOOD ASSOCIATION |
| 2014-07-17 | JAMES KEON | Doug Clark | Executive Director | Canadian Generic Pharmaceutical Association (CGPA) |
| 2014-03-26 | JAMES KEON | Doug Clark | Executive Director | Canadian Generic Pharmaceutical Association (CGPA) |
| 2014-01-23 | Frank Swedlove | Douglas Clark | Executive Director | Canadian Life and Health Insurance Association Inc. |
| 2013-12-09 | Jonathan Fairest | François Pilon | Député | |
| 2013-09-24 | ANDREW CASEY | Michelle Boudreau | Executive Director | BIOTECANADA |
| 2013-09-05 | Frank Swedlove | Michelle Boudreau | Executive Director | Canadian Life and Health Insurance Association Inc. |
| 2013-06-11 | JAMES KEON | Michelle Boudreau | Executive Director | Canadian Generic Pharmaceutical Association (CGPA) |
| 2012-07-26 | JAMES KEON | Michelle Boudreau | Executive Director | Canadian Generic Pharmaceutical Association (CGPA) |
| 2012-03-02 | Barry Fishman | Michelle Boudreau | Executive Director | Teva Canada Limited |
| 2012-03-02 | JAMES KEON | Michelle Boudreau | Executive Director | Canadian Generic Pharmaceutical Association (CGPA) |
| 2012-03-02 | Richard Guest | Michelle Boudreau | Executive Director | Mylan Pharmaceuticals ULC |
| 2012-03-02 | JACK KAY | Michelle Boudreau | Executive Director | Apotex Inc. |
| 2012-03-02 | Jean-Guy Goulet | Michelle Boudreau | Executive Director | Actavis Pharma Company |
| 2012-01-11 | JAMES KEON | Michelle Boudreau | Executive Director | Canadian Generic Pharmaceutical Association (CGPA) |
| 2011-12-09 | JAMES KEON | Michelle Boudreau | Executive Director | Canadian Generic Pharmaceutical Association (CGPA) |
| 2011-12-09 | JAMES KEON | Mary Catherine Lindberg | Chairperson | Canadian Generic Pharmaceutical Association (CGPA) |
| 2011-12-09 | Barry Fishman | Michelle Boudreau | Executive Director | Teva Canada Limited |
| 2011-12-09 | Barry Fishman | Mary Catherine Lindberg | Chairperson | Teva Canada Limited |
Ask a question about this data
Questions are reviewed before they appear. Your email is used only to let you know when your question has been answered.